Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Advanced Registry Search Results

Search History (1)

Search Criteria

Search for pfizer in registrations and monthly communication reports

Refine registrations results by

Status Type Subject matter Government institutions

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Registration (173)
Results: 1-50 | Export
  1. Pfizer Canada ULC
    Type: In-house Corporation
    Responsible officer: Najah Sampson, President
    Registration: 37 of 37 (2023-07-12 to present)
    Posted: 2023-07-14
    Subject matter details: 13
    Government institutions: 24
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 4
  2. Pfizer Canada ULC
    Type: In-house Corporation
    Responsible officer: Najah Sampson, President
    Registration: 36 of 37 (2023-03-31 to 2023-07-12)
    Posted: 2023-04-16
    Subject matter details: 12
    Government institutions: 24
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 5
  3. Pfizer Canada ULC
    Type: In-house Corporation
    Responsible officer: Najah Sampson, President
    Registration: 35 of 37 (2023-02-14 to 2023-03-31)
    Posted: 2023-03-16
    Subject matter details: 12
    Government institutions: 24
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 5
  4. Pfizer Canada ULC
    Type: In-house Corporation
    Responsible officer: Najah Sampson, President
    Registration: 34 of 37 (2022-05-16 to 2023-02-14)
    Posted: 2022-05-17
    Subject matter details: 13
    Government institutions: 25
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 5
  5. Pfizer Canada ULC
    Type: In-house Corporation
    Responsible officer: Cole C. Pinnow, President
    Registration: 33 of 37 (2021-12-01 to 2022-05-16)
    Posted: 2021-12-16
    Subject matter details: 13
    Government institutions: 25
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 5
  6. Pfizer Canada ULC
    Type: In-house Corporation
    Responsible officer: Cole C. Pinnow, President
    Registration: 32 of 37 (2021-09-15 to 2021-12-01)
    Posted: 2021-09-28
    Subject matter details: 13
    Government institutions: 25
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 5
  7. Pfizer Canada ULC
    Type: In-house Corporation
    Responsible officer: Cole C. Pinnow, President
    Registration: 31 of 37 (2021-06-15 to 2021-09-15)
    Posted: 2021-06-16
    Subject matter details: 13
    Government institutions: 23
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 5
  8. Pfizer Canada ULC
    Type: In-house Corporation
    Responsible officer: Cole C. Pinnow, President
    Registration: 30 of 37 (2021-02-14 to 2021-06-15)
    Posted: 2021-02-15
    Subject matter details: 12
    Government institutions: 23
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 5
  9. Pfizer Canada ULC
    Type: In-house Corporation
    Responsible officer: Cole C. Pinnow, President
    Registration: 29 of 37 (2021-01-29 to 2021-02-14)
    Posted: 2021-02-01
    Subject matter details: 12
    Government institutions: 23
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 4
  10. Pfizer Canada ULC
    Type: In-house Corporation
    Responsible officer: Cole C. Pinnow, President
    Registration: 28 of 37 (2020-11-01 to 2021-01-29)
    Posted: 2020-12-15
    Subject matter details: 11
    Government institutions: 23
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 4
  11. Canadian Biosimilars Forum / Forum canadien des biosimilaires
    Type: Consultant
    Lobbyist: Ross Wallace, Santis Health
    Registration: 5 of 5 (2020-08-05 to 2021-02-16)
    Posted: 2020-08-06
    Subject matter details: 1
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
  12. Pfizer Canada ULC
    Type: In-house Corporation
    Responsible officer: Cole C. Pinnow, President
    Registration: 27 of 37 (2020-08-03 to 2020-11-01)
    Posted: 2020-08-04
    Subject matter details: 10
    Government institutions: 22
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 4
  13. Pfizer Canada ULC
    Type: In-house Corporation
    Responsible officer: Cole C. Pinnow, President
    Registration: 26 of 37 (2020-04-15 to 2020-08-03)
    Posted: 2020-04-27
    Subject matter details: 10
    Government institutions: 22
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 4
  14. Pfizer Canada ULC
    Type: In-house Corporation
    Responsible officer: Cole C. Pinnow, President
    Registration: 25 of 37 (2020-01-06 to 2020-04-15)
    Posted: 2020-02-17
    Subject matter details: 10
    Government institutions: 22
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 4
  15. Pfizer Canada ULC
    Type: In-house Corporation
    Responsible officer: John Helou, Président et chef de la direction
    Registration: 24 of 37 (2019-06-14 to 2020-01-06)
    Posted: 2019-07-02
    Subject matter details: 10
    Government institutions: 22
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 4
  16. Canadian Biosimilars Forum / Forum canadien des biosimilaires
    Type: Consultant
    Lobbyist: Ross Wallace, Santis Health
    Registration: 4 of 5 (2019-04-18 to 2020-08-05)
    Posted: 2019-04-24
    Subject matter details: 1
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
  17. Pfizer Canada ULC
    Type: In-house Corporation
    Responsible officer: John Helou, Président et chef de la direction
    Registration: 23 of 37 (2018-08-01 to 2019-06-14)
    Posted: 2018-09-18
    Subject matter details: 12
    Government institutions: 22
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 4
  18. Life Sciences Ontario (LSO)
    Type: Consultant
    Lobbyist: Muhammad Ali, Hill+Knowlton Strategies / Hill+Knowlton Stratégies
    Registration: 2 of 2 (2018-07-10 to 2019-02-15)
    Posted: 2018-07-10
    Subject matter details: 1
    Government institutions: 4
    Communication techniques: 2
    Government funding: No
  19. Life Sciences Ontario (LSO)
    Type: Consultant
    Lobbyist: Muhammad Ali, Hill+Knowlton Strategies / Hill+Knowlton Stratégies
    Registration: 1 of 2 (2018-01-11 to 2018-06-15)
    Posted: 2018-01-12
    Subject matter details: 1
    Government institutions: 4
    Communication techniques: 2
    Government funding: No
  20. Pfizer Canada ULC
    Type: In-house Corporation
    Responsible officer: John Helou, Président et chef de la direction
    Registration: 22 of 37 (2018-01-08 to 2018-08-01)
    Posted: 2018-01-12
    Subject matter details: 11
    Government institutions: 22
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 4
  21. Life Sciences Ontario (LSO)
    Type: Consultant
    Lobbyist: Omar Khan, Hill+Knowlton Strategies
    Registration: 1 of 1 (2018-01-05 to 2018-07-17)
    Posted: 2018-01-12
    Subject matter details: 1
    Government institutions: 4
    Communication techniques: 2
    Government funding: No
  22. Canadian Biosimilars Forum / Forum canadien des biosimilaires
    Type: Consultant
    Lobbyist: Ross Wallace, Santis Health
    Registration: 3 of 5 (2017-11-02 to 2019-04-18)
    Posted: 2017-11-07
    Subject matter details: 1
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
  23. Pfizer Canada ULC
    Type: In-house Corporation
    Responsible officer: John Helou, Président et chef de la direction
    Registration: 21 of 37 (2017-08-04 to 2018-01-08)
    Posted: 2017-08-21
    Subject matter details: 10
    Government institutions: 22
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 4
  24. Canadian Biosimilars Forum / Forum canadien des biosimilaires
    Type: Consultant
    Lobbyist: Ross Wallace, Santis Health
    Registration: 2 of 5 (2017-06-04 to 2017-11-02)
    Posted: 2017-06-05
    Subject matter details: 1
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
  25. Pfizer Canada ULC
    Type: In-house Corporation
    Responsible officer: John Helou, Président et chef de la direction
    Registration: 20 of 37 (2017-02-23 to 2017-08-04)
    Posted: 2017-02-24
    Subject matter details: 12
    Government institutions: 22
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 4
  26. Arthritis Alliance of Canada
    Type: Consultant
    Lobbyist: Ashley Brambles, Hill+Knowlton Strategies
    Registration: 1 of 1 (2016-12-05 to 2017-01-13)
    Posted: 2016-12-19
    Subject matter details: 1
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  27. Canadian Biosimilars Forum / Forum canadien des biosimilaires
    Type: Consultant
    Lobbyist: Ross Wallace, Santis Health
    Registration: 1 of 5 (2016-11-22 to 2017-06-04)
    Posted: 2016-12-07
    Subject matter details: 1
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
  28. Pfizer Canada ULC
    Type: In-house Corporation
    Responsible officer: John Helou, Président et chef de la direction
    Registration: 19 of 37 (2016-10-31 to 2017-02-23)
    Posted: 2016-10-31
    Subject matter details: 11
    Government institutions: 22
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 4
  29. Arthritis Alliance of Canada / Alliance de l'arthrite du Canada
    Type: Consultant
    Lobbyist: Sarah Bain, Hill+Knowlton Strategies
    Registration: 2 of 2 (2016-09-30 to 2017-02-16)
    Posted: 2016-10-05
    Subject matter details: 1
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  30. Arthritis Alliance of Canada
    Type: Consultant
    Lobbyist: Shannon Donnelly, Hill+Knowlton Strategies
    Registration: 1 of 1 (2016-06-06 to 2016-11-16)
    Posted: 2016-06-13
    Subject matter details: 1
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  31. Arthritis Alliance of Canada
    Type: Consultant
    Lobbyist: Michelle McLean, Hill+Knowlton Strategies
    Registration: 2 of 2 (2016-06-01 to 2017-05-15)
    Posted: 2016-07-21
    Subject matter details: 1
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  32. Arthritis Alliance of Canada / Alliance de l'arthrite du Canada
    Type: Consultant
    Lobbyist: Allison St-Jean, Hill+Knowlton Strategies
    Registration: 2 of 2 (2016-04-14 to 2017-04-10)
    Posted: 2016-04-21
    Subject matter details: 1
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  33. Pfizer Canada ULC
    Type: In-house Corporation
    Responsible officer: John Helou, Président et chef de la direction
    Registration: 18 of 37 (2016-04-04 to 2016-10-31)
    Posted: 2016-04-07
    Subject matter details: 10
    Government institutions: 25
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 4
  34. Arthritis Alliance of Canada / Alliance de l'arthrite du Canada
    Type: Consultant
    Lobbyist: Sarah Bain, Hill+Knowlton Strategies
    Registration: 1 of 2 (2016-04-01 to 2016-08-30)
    Posted: 2016-04-05
    Subject matter details: 1
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  35. Arthritis Alliance of Canada / Alliance de l'arthrite du Canada
    Type: Consultant
    Lobbyist: Allison St-Jean
    Registration: 1 of 2 (2016-03-14 to 2016-04-14)
    Posted: 2016-03-17
    Subject matter details: 1
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  36. Pfizer Canada ULC
    Type: In-house Corporation
    Responsible officer: John Helou, Président et chef de la direction
    Registration: 17 of 37 (2016-03-04 to 2016-04-04)
    Posted: 2016-03-08
    Subject matter details: 10
    Government institutions: 25
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 3
  37. Arthritis Alliance of Canada
    Type: Consultant
    Lobbyist: Michelle McLean, Hill+Knowlton Strategies
    Registration: 1 of 2 (2016-02-09 to 2016-06-01)
    Posted: 2016-03-09
    Subject matter details: 1
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  38. Pfizer Canada ULC
    Type: In-house Corporation
    Responsible officer: John Helou, Président et chef de la direction
    Registration: 16 of 37 (2015-10-15 to 2016-03-04)
    Posted: 2015-10-15
    Subject matter details: 10
    Government institutions: 25
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 4
  39. Pfizer Canada ULC
    Type: In-house Corporation
    Responsible officer: John Helou, Président et chef de la direction
    Registration: 15 of 37 (2014-12-31 to 2015-10-15)
    Posted: 2014-12-31
    Subject matter details: 11
    Government institutions: 25
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 5
  40. Pfizer Canada ULC
    Type: In-house Corporation
    Responsible officer: John Helou, Président et chef de la direction
    Registration: 14 of 37 (2014-05-23 to 2014-12-31)
    Posted: 2014-06-04
    Subject matter details: 10
    Government institutions: 25
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 5
  41. PFIZER CANADA INC.
    Type: Consultant
    Lobbyist: LISA SAMSON, STRATEGYCORP OTTAWA
    Registration: 10 of 10 (2013-10-25 to 2014-06-10)
    Posted: 2013-10-29
    Subject matter details: 4
    Government institutions: 9
    Communication techniques: 3
    Government funding: No
  42. Pfizer Canada ULC
    Type: In-house Corporation
    Responsible officer: John Helou, Président et chef de la direction
    Registration: 13 of 37 (2013-01-28 to 2014-05-23)
    Posted: 2013-01-28
    Subject matter details: 10
    Government institutions: 26
    Communication techniques: 4
    Government funding: No
    Employees who lobby: 6
  43. PFIZER CANADA INC.
    Type: Consultant
    Lobbyist: LISA SAMSON, STRATEGYCORP OTTAWA
    Registration: 9 of 10 (2012-11-05 to 2013-10-25)
    Posted: 2012-11-15
    Subject matter details: 4
    Government institutions: 9
    Communication techniques: 3
    Government funding: No
  44. Pfizer Canada Inc.
    Type: Consultant
    Lobbyist: Robert Rosenfeld, StrategyCorp Inc.
    Registration: 1 of 1 (2012-11-05 to 2013-04-24)
    Posted: 2012-11-15
    Subject matter details: 2
    Government institutions: 9
    Communication techniques: 3
    Government funding: No
  45. Arthritis Alliance of Canada / Alliance de l'arthrite du Canada
    Type: Consultant
    Lobbyist: Cameron Summers, Edelman Canada
    Registration: 2 of 2 (2012-08-15 to 2013-02-02)
    Posted: 2012-08-16
    Subject matter details: 2
    Government institutions: 4
    Communication techniques: 3
    Government funding: No
  46. Pfizer Canada ULC
    Type: In-house Corporation
    Responsible officer: John Helou, Président et chef de la direction
    Registration: 12 of 37 (2012-08-10 to 2013-01-28)
    Posted: 2012-08-13
    Subject matter details: 10
    Government institutions: 27
    Communication techniques: 4
    Government funding: No
    Employees who lobby: 6
  47. Pfizer Canada ULC
    Type: In-house Corporation
    Responsible officer: John Helou, Président et chef de la direction
    Registration: 11 of 37 (2012-05-14 to 2012-08-10)
    Posted: 2012-05-15
    Subject matter details: 10
    Government institutions: 26
    Communication techniques: 4
    Government funding: No
    Employees who lobby: 6
  48. PFIZER CANADA INC.
    Type: Consultant
    Lobbyist: GOLDY HYDER, HILL + KNOWLTON STRATEGIES
    Registration: 9 of 9 (2012-02-14 to 2012-11-01)
    Posted: 2012-02-15
    Subject matter details: 1
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
  49. Arthritis Alliance of Canada / Alliance de l'arthrite du Canada
    Type: Consultant
    Lobbyist: Cameron Summers, Edelman Canada
    Registration: 1 of 2 (2012-02-06 to 2012-08-15)
    Posted: 2012-02-24
    Subject matter details: 2
    Government institutions: 2
    Communication techniques: 3
    Government funding: No
  50. Pfizer Canada ULC
    Type: In-house Corporation
    Responsible officer: John Helou, Président et chef de la direction
    Registration: 10 of 37 (2012-01-30 to 2012-05-14)
    Posted: 2012-04-04
    Subject matter details: 10
    Government institutions: 26
    Communication techniques: 4
    Government funding: No
    Employees who lobby: 6
Monthly communication reports (319)
Results: 1-50 | Export
  1. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2024-02-14
    Posted: 2024-03-15
    Designated public office holders:
    • Francois-Phillipe Champagne, Minister | Innovation, Science and Economic Development Canada (ISED)
    • Mary Ng, Minister of Export Promotion, International Trade and Economic Development | Global Affairs Canada (GAC)
    Subject matters:
    • International Trade
    • International Relations
    • Industry
      •
  2. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2024-02-06
    Posted: 2024-03-15
    Designated public office holders:
    • Dr. Stephen Ellis, Member of Parliament | House of Commons
    Subject matters:
    • Industry
    • International Trade
    • Health
      •
  3. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2024-02-01
    Posted: 2024-03-15
    Designated public office holders:
    • Randy Hoback, Member of Parliament | House of Commons
    Subject matters:
    • Industry
    • International Trade
    • Health
      •
  4. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2023-12-12
    Posted: 2024-01-15
    Designated public office holders:
    • Jennifer Miller, Assistant Secretary | Privy Council Office (PCO)
    Subject matters:
    • Industry
    • Health
      •
  5. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2023-12-12
    Posted: 2024-01-15
    Designated public office holders:
    • Jean-Sebastien Bock, Deputy Chief of Staff and Director of Policy, Office of the Minister of Health | Health Canada (HC)
    • Eshan Naik, Director of Policy, Office of the Minister of Health | Health Canada (HC)
    Subject matters:
    • Health
    • Industry
      •
  6. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2023-12-12
    Posted: 2024-01-15
    Designated public office holders:
    • Christopher Johnstone, Assistant Deputy Minister | Health Canada (HC)
    • Dr. Stephen Lucas, Deputy Minister | Health Canada (HC)
    Subject matters:
    • Health
    • Industry
      •
  7. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2023-11-07
    Posted: 2023-12-15
    Designated public office holders:
    • Marie-Françoise Mégie, Senatrice | Senate of Canada
    Subject matters:
    • Industry
    • Health
      •
  8. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2023-11-07
    Posted: 2023-12-15
    Designated public office holders:
    • Alexis Conrad, Assistant Secretary to the Cabinet, Economic Regional Development Policy | Privy Council Office (PCO)
    • Jeff Waring, Associate Assistant Secretary | Privy Council Office (PCO)
    • Jennifer Miller, Assistant Secretary | Privy Council Office (PCO)
    Subject matters:
    • Health
    • Industry
      •
  9. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2023-11-06
    Posted: 2023-12-15
    Designated public office holders:
    • Dr. Stephen Lucas, Deputy Minister | Health Canada (HC)
    • Pamela AUNG-THIN, Assistant Deputy Minister, Health Products and Food Branch | Health Canada (HC)
    Subject matters:
    • Industry
    • Health
      •
  10. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2023-11-06
    Posted: 2023-12-15
    Designated public office holders:
    • Carol Hughes, Member of Parliament | House of Commons
    Subject matters:
    • Industry
    • Health
      •
  11. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2023-11-06
    Posted: 2023-12-15
    Designated public office holders:
    • Andrew Cardozo, Senator | Senate of Canada
    Subject matters:
    • Industry
    • Health
      •
  12. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2023-11-06
    Posted: 2023-12-15
    Designated public office holders:
    • Stan Kutcher, Senator | Senate of Canada
    Subject matters:
    • Industry
    • Health
      •
  13. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2023-10-26
    Posted: 2023-11-16
    Designated public office holders:
    • Ritu Banerjee , Assistant Deputy Minister, Office of Life Sciences and Biomanufacturing Readiness (OLSBR) | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Industry
      •
  14. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2023-10-05
    Posted: 2023-11-16
    Designated public office holders:
    • Stefania Trombetti, Assistant Deputy Minister, Drug Shortages Task Force | Health Canada (HC)
    Subject matters:
    • Health
      •
  15. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2023-09-25
    Posted: 2023-10-16
    Designated public office holders:
    • Jean-Yves Duclos, Minister | Public Services and Procurement Canada (PSPC)
    Subject matters:
    • Government Procurement
      •
  16. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2023-09-20
    Posted: 2023-10-16
    Designated public office holders:
    • Simon Kennedy, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Christopher Johnstone, Assistant Deputy Minister | Health Canada (HC)
    Subject matters:
    • Industry
    • Health
    • International Trade
      •
  17. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2023-07-12
    Posted: 2023-08-15
    Designated public office holders:
    • Celia Lourenco, Acting Associate Assistant Deputy Minister, Health Products and Food Branch | Health Canada (HC)
    • Pamela AUNG-THIN, Assistant Deputy Minister, Health Products and Food Branch | Health Canada (HC)
    Subject matters:
    • Industry
    • Health
      •
  18. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2023-07-12
    Posted: 2023-08-15
    Designated public office holders:
    • Ritu BANERJEE, Associate Deputy Minister, Office of Life Sciences and Biomanufacturing Readiness | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Industry
    • Health
      •
  19. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2023-07-12
    Posted: 2023-08-15
    Designated public office holders:
    • Tina Green, Assistant Secretary, Regulatory Affairs Sector | Treasury Board Of Canada Secretariat (TBS)
    Subject matters:
    • Health
    • Industry
      •
  20. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2023-07-04
    Posted: 2023-08-15
    Designated public office holders:
    • Stefania Trombetti, Assistant Deputy Minister | Health Canada (HC)
    Subject matters:
    • Health
    • Industry
      •
  21. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2023-06-16
    Posted: 2023-07-15
    Designated public office holders:
    • Jean-Yves Duclos, Minister of Health | Health Canada (HC)
    • Sandenga Yeba , Deputy Director of Policy, Office of the Minister | Health Canada (HC)
    • Stephen Lucas, Deputy Minister | Health Canada (HC)
    • Stefania Trombetti, Assistant Deputy Minister | Health Canada (HC)
    Subject matters:
    • Health
    • Industry
      •
  22. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2023-04-25
    Posted: 2023-05-15
    Designated public office holders:
    • Jocelyne Voisin, Assistant Deputy Minister, Strategic Policy Branch | Health Canada (HC)
    Subject matters:
    • Health
      •
  23. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2023-04-04
    Posted: 2023-05-15
    Designated public office holders:
    • James Fitz-Morris, Director of Communications, Office of the Minister | Public Services and Procurement Canada (PSPC)
    Subject matters:
    • Government Procurement
      •
  24. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2023-03-27
    Posted: 2023-04-15
    Designated public office holders:
    • Arianne Reza, Associate Deputy Minister | Public Services and Procurement Canada (PSPC)
    Subject matters:
    • Government Procurement
      •
  25. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2023-03-14
    Posted: 2023-04-15
    Designated public office holders:
    • James Fitz-Morris, Director of Communications, Office of the Minister | Public Services and Procurement Canada (PSPC)
    Subject matters:
    • Government Procurement
      •
  26. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2023-03-08
    Posted: 2023-04-15
    Designated public office holders:
    • Arianne Reza, Associate Deputy Minister | Public Services and Procurement Canada (PSPC)
    Subject matters:
    • Government Procurement
      •
  27. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2023-03-02
    Posted: 2023-04-15
    Designated public office holders:
    • Francois-Phillipe Champagne, Minister | Innovation, Science and Economic Development Canada (ISED)
    • Ian Foucher, Chief of Staff, Office of the Minister of Innovation, Science and Industry | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Industry
    • Economic Development
      •
  28. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2023-02-16
    Posted: 2023-03-15
    Designated public office holders:
    • Rick Theis, Director, COVID-19 Response | Prime Minister's Office (PMO)
    Subject matters:
    • Government Procurement
      •
  29. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2023-02-14
    Posted: 2023-03-15
    Designated public office holders:
    • Arianne Reza, Associate Deputy Minister | Public Services and Procurement Canada (PSPC)
    Subject matters:
    • Government Procurement
      •
  30. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2023-02-14
    Posted: 2023-03-15
    Designated public office holders:
    • Cory Pike, Chief of Staff to the Minister, Office of the Minister | Public Services and Procurement Canada (PSPC)
    Subject matters:
    • Government Procurement
      •
  31. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2023-01-16
    Posted: 2023-02-15
    Designated public office holders:
    • Francois-Phillipe Champagne, Minister | Innovation, Science and Economic Development Canada (ISED)
    • Ian Foucher, Chief of Staff, Office of the Minister of Innovation, Science and Industry | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Industry
      •
  32. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2022-09-22
    Posted: 2022-10-15
    Designated public office holders:
    • Eric Belair, Associate Assistant Deputy Minister, Strategic Policy Branch | Health Canada (HC)
    Subject matters:
    • Health
      •
  33. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2022-09-22
    Posted: 2022-10-15
    Designated public office holders:
    • Eric Costen, Assistant Deputy Minister, Industry Sector | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Research and Development
    • Industry
    • Intellectual Property
      •
  34. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2022-09-22
    Posted: 2022-10-15
    Designated public office holders:
    • Jean-Sebastien Bock, Director of Policy, Office of the Minister of Health | Health Canada (HC)
    • Sandenga Yeba , Senior Policy Advisor, Office of the Minister | Health Canada (HC)
    • Jean-Yves Duclos, Minister of Health | Health Canada (HC)
    Subject matters:
    • Research and Development
    • Health
      •
  35. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2022-08-25
    Posted: 2022-08-26
    Designated public office holders:
    • Eric Costen, Assistant Deputy Minister, Industry Sector | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • International Trade
    • Health
    • Industry
      •
  36. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2022-07-21
    Posted: 2022-08-15
    Designated public office holders:
    • Seamus O'Regan, Minister of Labour | Employment and Social Development Canada (ESDC)
    Subject matters:
    • Labour
    • Industry
    • International Trade
      •
  37. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2022-07-11
    Posted: 2022-08-15
    Designated public office holders:
    • Stevie O'Brien, Chief of Staff, Office of the Minister | Public Services and Procurement Canada (PSPC)
    • Cory Pike, Senior Advisor, Office of the Minister | Public Services and Procurement Canada (PSPC)
    • Filomena Tassi, Minister | Public Services and Procurement Canada (PSPC)
    • Arianne Reza, Associate Deputy Minister | Public Services and Procurement Canada (PSPC)
    Subject matters:
    • Government Procurement
      •
  38. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2022-06-28
    Posted: 2022-07-15
    Designated public office holders:
    • Simon Kennedy, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Intellectual Property
    • Science and Technology
    • Industry
    • International Trade
    • Health
      •
  39. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2022-06-27
    Posted: 2022-07-15
    Designated public office holders:
    • Nancy Hamzawi, Assistant Deputy Minister, Health Products and Food Branch | Health Canada (HC)
    • Stephen Lucas, Deputy Minister | Health Canada (HC)
    Subject matters:
    • Industry
    • Intellectual Property
    • Health
    • International Trade
    • Science and Technology
      •
  40. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2022-06-15
    Posted: 2022-07-15
    Designated public office holders:
    • Stevie O'Brien, Chief of Staff, Office of the Minister | Public Services and Procurement Canada (PSPC)
    Subject matters:
    • Government Procurement
      •
  41. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2022-05-30
    Posted: 2022-06-15
    Designated public office holders:
    • Eric Costen, Assistant Deputy Minister, Industry Sector | Innovation, Science and Economic Development Canada (ISED)
    • Simon Kennedy, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Health
    • Research and Development
    • Industry
      •
  42. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2022-05-12
    Posted: 2022-06-15
    Designated public office holders:
    • Filomena Tassi, Minister | Public Services and Procurement Canada (PSPC)
    • Paul Thompson, Deputy Minister | Public Services and Procurement Canada (PSPC)
    • Stevie O'Brien, Chief of Staff, Office of the Minister | Public Services and Procurement Canada (PSPC)
    • James Fitz-Morris, Director of Communications, Office of the Minister | Public Services and Procurement Canada (PSPC)
    Subject matters:
    • Government Procurement
      •
  43. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2022-04-21
    Posted: 2022-05-15
    Designated public office holders:
    • Bianca Hossain, Sr Special Assistant, Office of the Minister | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Industry
      •
  44. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2022-04-19
    Posted: 2022-05-15
    Designated public office holders:
    • Jean-Sébastien Bock, Directeur des politiques, Bureau du Ministre | Health Canada (HC)
    • Jean-Yves Duclos, Minister of Health | Health Canada (HC)
    Subject matters:
    • Health
      •
  45. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2022-04-13
    Posted: 2022-05-15
    Designated public office holders:
    • Stevie O'Brien, Chief of Staff, Office of the Minister | Public Services and Procurement Canada (PSPC)
    Subject matters:
    • Government Procurement
      •
  46. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2022-04-01
    Posted: 2022-05-15
    Designated public office holders:
    • Stevie O'Brien, Chief of Staff, Office of the Minister | Public Services and Procurement Canada (PSPC)
    Subject matters:
    • Government Procurement
      •
  47. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2022-03-24
    Posted: 2022-04-16
    Designated public office holders:
    • Stephen Bent , Acting Vice President, Vaccine Rollout Task Force | Public Health Agency of Canada (PHAC)
    • Eric Costen, Assistant Deputy Minister, Industry Sector | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Government Procurement
    • Industry
      •
  48. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2022-03-23
    Posted: 2022-04-16
    Designated public office holders:
    • Bianca Hossain, Sr Special Assistant, Office of the Minister | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Industry
      •
  49. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2022-03-17
    Posted: 2022-04-16
    Designated public office holders:
    • Francois-Phillipe Champagne, Minister | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Industry
      •
  50. Pfizer Canada ULC
    Type: In-house Corporation
    Occurred: 2022-02-25
    Posted: 2022-03-28
    Designated public office holders:
    • Heather Jeffrey, Associate Deputy Minister | Health Canada (HC)
    • Stephen Lucas, Deputy Minister | Health Canada (HC)
    Subject matters:
    • Industry
    • Health
      •
Date Modified: